Riskpilot← Back to searchSign inGet full accessPHARMCO I ApS
APSActiveCVR 25204042Tinglykke 4-6Activities of holding companies · NACE 6421Est. 2000— employees
Revenue 2024
DKK 0
EBITDA margin
—
+13% vs 2023
Equity ratio
98.1%
Financial strength
Net profit 2024
DKK 44,8M
+39% vs 2023
| Revenue | DKK 0 | — |
| EBITDA | DKK -98K | +13% |
| Net profit | DKK 44,8M | +39% |
| Total assets | DKK 417,7M | +14% |
| Equity | DKK 409,7M | +12% |
| Employees | — | — |
Legal name
PHARMCO I ApS
CVR number
25204042
Legal form
Anpartsselskab
NACE code
6421 · Activities of holding companies
Founded
4. februar 2000
Share capital
DKK 125.000
Employees
—
VAT registered
No
Audit selected
Yes
Last report
2024-12-31
Financial year
January – December
Signatory rights
Selskabet tegnes af direktøren
Company purpose
Selskabets formål er at besidde kapitalandel i andre selskaber samt hermed beslægtet virksomhed
Address
Tinglykke 4-6
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2000 | 2001 | 2002 | 2003 | 2004 | 2005 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | — | — | — | — | — | — | — | — | — | — | — | — | — | 0 | 0 | — | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Staff expenses | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 |
| EBITDA | — | — | — | — | — | — | — | — | — | — | — | — | — | -53 | -60 | 30.710 | -65 | -66 | -66 | -66 | -82 | -69 | -72 | -112 | -98 |
| Depreciation & amort. | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -6 | -6 |
| EBIT | — | — | — | — | — | — | — | — | — | — | — | — | — | -53 | -60 | 30.710 | -65 | -66 | -66 | -66 | -82 | -69 | -72 | -118 | -104 |
| Net financials | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 7.329 | 18.184 | 0 | 36.714 | 28.721 | 18.611 | 32.973 | 36.870 | 44.836 | 16.169 | 37.290 | 51.649 |
| Profit before tax | — | — | — | — | — | — | — | — | — | — | — | — | — | 7.276 | 18.124 | 30.710 | 36.649 | 28.655 | 18.545 | 32.907 | 36.788 | 44.767 | 16.097 | 37.172 | 51.545 |
| Tax | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | 433 | 339 | -0 | 559 | 613 | -533 | 1.304 | 668 | 1.564 | -1.445 | 4.875 | 6.741 |
| Net profit | — | — | — | — | — | — | — | — | — | — | — | — | — | 6.843 | 17.785 | 30.710 | 36.090 | 28.042 | 19.078 | 31.603 | 36.120 | 43.203 | 17.542 | 32.297 | 44.804 |
| Item | 2000 | 2001 | 2002 | 2003 | 2004 | 2005 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 62.667 | 82.012 | 48.687 | 155.200 | 179.862 | 214.460 | 255.543 | 274.228 | 331.534 | 336.643 | 367.442 | 417.714 |
| Equity | — | — | — | — | — | — | — | — | — | — | — | — | — | 62.652 | 80.292 | 125 | 144.504 | 171.498 | 190.652 | 237.152 | 272.457 | 316.282 | 332.779 | 364.555 | 409.700 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 16.527 | 12.452 | 0 | 0 | 0 | 0 | 0 |
| Short-term debt | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 15 | 1.720 | 0 | 10.696 | 8.364 | 7.281 | 5.939 | 1.771 | 15.252 | 3.864 | 2.886 | 8.013 |
| Total debt | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 15 | 1.720 | 0 | 10.696 | 8.364 | 23.808 | 18.391 | 1.771 | 15.252 | 3.864 | 2.886 | 8.013 |
EBITDA margin
-9800000.0%
This company
15.8%
Market median
-62025416% vs market
20002024
Equity ratio
98.1%
This company
38.2%
Market median
+157% vs market
20002024
Return on equity
10.9%
This company
18.4%
Market median
+41% vs market
20002024
Net profit margin
4480400000.0%
This company
8.1%
Market median
+55313580147% vs market
20002024
Asset turnover
0.00×
This company
1.12×
Market median
-100% vs market
20002024
Debt / equity
0.02×
This company
0.62×
Market median
+97% vs market
20002024
- Annual report 2024Filed via CVR / Virk · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via CVR / Virk · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via CVR / Virk · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via CVR / Virk · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via CVR / Virk · Period 2020-01-01 – 2020-12-31
- Annual report 2019Filed via CVR / Virk · Period 2019-01-01 – 2019-12-31
- Annual report 2018Filed via CVR / Virk · Period 2018-01-01 – 2018-12-31
- Annual report 2017Filed via CVR / Virk · Period 2017-01-01 – 2017-12-31
- Annual report 2016Filed via CVR / Virk · Period 2016-01-01 – 2016-12-31
- Annual report 2015Filed via CVR / Virk · Period 2015-01-01 – 2015-12-31
- Annual report 2014Filed via CVR / Virk · Period 2014-01-01 – 2014-12-31
- Annual report 2013Filed via CVR / Virk · Period 2013-01-01 – 2013-12-31
- Annual report 2012Filed via CVR / Virk · Period 2012-01-01 – 2012-12-31
- Annual report 2011Filed via CVR / Virk · Period 2011-01-01 – 2011-12-31
- Annual report 2010Filed via CVR / Virk · Period 2010-01-01 – 2010-12-31
- Annual report 2009Filed via CVR / Virk · Period 2009-01-01 – 2009-12-31
- Annual report 2008Filed via CVR / Virk · Period 2008-01-01 – 2008-12-31
- Annual report 2007Filed via CVR / Virk · Period 2007-01-01 – 2007-12-31
- Annual report 2006Filed via CVR / Virk · Period 2006-01-01 – 2006-12-31
- Annual report 2005Filed via CVR / Virk · Period 2005-01-01 – 2005-12-31
- Annual report 2004Filed via CVR / Virk · Period 2004-01-01 – 2004-12-31
- Annual report 2003Filed via CVR / Virk · Period 2003-01-01 – 2003-12-31
- Annual report 2002Filed via CVR / Virk · Period 2002-01-01 – 2002-12-31
- Annual report 2001Filed via CVR / Virk · Period 2001-01-01 – 2001-12-31
- Annual report 2000Filed via CVR / Virk · Period 2000-02-04 – 2000-12-31
No data on file.
No data on file.
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Individual | 100.0% | 100.0% | 2000 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
PHARMCO I ApS 
PHARMA NORD ApSBoard members of PHARMCO I ApS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|